S

Structure Therapeutics

Company profile · headcount, org chart & B2B contacts

76 Decision makers
+17 New (6 months)
500 Employees
2017 Founded

Organizational Chart of Structure Therapeutics

Roles identified within Structure Therapeutics's leadership team, based on public professional data.

Department

Hiring This department is actively hiring right now.

Structure Therapeutics's Full Organizational Chart

Loading


Get their contacts on Zeliq →

Job title Department People Action

Decision-maker contacts at Structure Therapeutics

Unlock emails & phones →

Decision makers at Structure Therapeutics

76 identified 5 C-Level 14 VP 57 Directors +17 new (6 months)
See them on Zeliq →

Departments actively hiring 7 departments

Engineering and technical
Finance & accounting
General management
Medical
Other
Project management
Research

These departments at Structure Therapeutics are actively recruiting: a strong signal to time your outreach.

Latest news at Structure Therapeutics

  1. Appointment

    New Head of Ai Engineering appointed — Engineering and technical

  2. Appointment

    New Director, Analytical Development appointed — Research

  3. Appointment

    New Associate Director, Biology appointed — Research

  4. Appointment

    New Associate Director of Medical Writing appointed — Medical

  5. Appointment

    New Associate Director appointed — General management

Get these new hires' email and phone →

Funding

Last round Other · $748M
Total funding $2.0B (9 rounds)
Series A $16M Apr 2019
Series A $26M Mar 2020
Series B $33M Oct 2021
Series B $100M Oct 2021
Series B $33M Aug 2022
Post-IPO Equity $185M Feb 2023
Post-IPO Equity $300M Sep 2023
Post-IPO Equity $547M Jun 2024
Post-IPO Equity $748M Dec 2025

Team Structure headcount by department

Hiring Research
43
Hiring Medical
34
Hiring General Management
21
Hiring Other
18
Hiring Finance
14
HR
13
Legal
9
Operations
9

Companies similar to Structure Therapeutics

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Structure Therapeutics

Structure Therapeutics is a Biotechnology Research company, based in United States. Founded in 2017, the company employs approximately 500 people. As part of the broader Professional Services sector, Structure Therapeutics operates specifically in the Biotechnology Research segment. Structure Therapeutics is a B2B company, primarily serving business clients and professional organisations. The company has secured 9 rounds of funding totalling $2.0B. This profile compiles key information about Structure Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Structure Therapeutics is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Structure Therapeutics primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.

How to prospect Structure Therapeutics's departments

Research

With 43 people, this is the organisation's biggest team, and it is hiring. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Medical

Hiring is underway in this team of 34 people. Time with patients is the priority: position your solution as a way to give hours back to care.

General Management

A team of 21 people, currently hiring. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Other

This 18-person department is actively recruiting. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Finance

Hiring is underway in this team of 14 people. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

Project Management

A team of 8 people, currently hiring. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.

FAQ Structure Therapeutics

What industry does Structure Therapeutics operate in?

Structure Therapeutics is active in the Biotechnology Research industry, specifically in the Professional Services category.

How many employees does Structure Therapeutics have?

Structure Therapeutics has approximately 500 employees (in the 201-500 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Structure Therapeutics?

Zeliq lets you identify decision makers at Structure Therapeutics, enrich their professional contact details (verified emails and direct phone numbers), and launch targeted multichannel prospecting sequences.

Where is Structure Therapeutics headquartered?

Structure Therapeutics is headquartered in United States.

Which departments are hiring at Structure Therapeutics?

Hiring is currently active at Structure Therapeutics in these departments: Engineering and technical, Finance & accounting, General management. A useful signal to prioritise and time your prospecting.

What is the organizational chart of Structure Therapeutics?

Based on public professional data, Structure Therapeutics's organizational chart includes roles such as CTO, CEO, Associate Director, Director. Zeliq lets you find the verified contact details behind each of these roles.

Which decision makers recently joined Structure Therapeutics?

In the last 6 months, Structure Therapeutics appointed new decision makers including Head of Ai Engineering, Director, Analytical Development, Associate Director, Biology, Associate Director of Medical Writing, Associate Director. Newly appointed leaders typically review tools and vendors early on — their verified contacts are available on Zeliq.

Why use this data before prospecting Structure Therapeutics?

Industry, headcount and business signals give you the context to qualify Structure Therapeutics, tailor your messaging, and focus your effort on the right decision makers.